SYNOVO GMBH
- Country
- Germany
- Type
- Beneficiary
- Website
- www.synovo.com
- Grants received
- 10
Funding record
- 10 grants on record
- €3,863,192.12 awarded in total
- 2008–2021 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
4 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- UNIVERSITAET FUER BODENKULTUR WIEN
- ASSOCIACAO UNIVERSIDADE EMPRESA PARA DESENVOLVIMENTO TECMINHO
- BAR ILAN UNIVERSITY
- DI DR ANDREAS PAAR KG
- EBERHARD KARLS UNIVERSITAET TUEBINGEN
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR-IBMC
- MEDIZINISCHE UNIVERSITAET WIEN
Calls from this organisation
No published calls from this organisation.
Grants received
- ALGAE4IBD –FROM NATURE TO BEDSIDE- ALGAE BASED BIO COMPOUND FOR PREVENTION AND TREATMENT OF INFLAMMATION, PAIN AND IBD
- ''One size fits all'' unique drug to eradicate multiple viral species simultaneously from the central nervous system of co-infected individuals
- Folate-Target Nanodevices To Activated Macrophages For Rheumatoid Arthritis
- Functional materials for fast diagnosis of wound infection
- Tumor Infiltrating Myeloid Cell Compartment
- Prolonged inhibition of semaphorine3a pathway via a bio-degradable implant towards a better therapy for visual sensory impairments
- Novel approaches for prevention and degeneration of pathogenic bacteria biofilms formed on medical devices e.g. catheters
- Folate-based nanobiodevices for integrated diagnosis/therapy targeting chronic inflammatory diseases
- Selected peptides as drug candidates directed to pain and neurodegeneration
- Novel anti-inflammatory compounds for autoimmune diseases
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.